chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fever; body pain; Headache; This is a spontaneous report from a contactable Nurse (patient). This 40-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 07Jan2021 07:30 A.M. on Arm left at single dose (Lot # EL1283) for covid-19 immunisation. No other vaccine in four weeks. Medical history included Thyroid Cancer. None known allergies. No COVID prior vaccination. Concomitant medications included Levothyroxine and ubrogepant (UBRELVY). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 18Dec2020 04:00 P.M. on Arm left at single dose (Lot # EK5730) for covid-19 immunisation. The patient experienced headache started the day of 07Jan2021 at 21:30. Fever and body pain 08Jan2021 01:30 until 23:30. Lab data included Nasal Swab and COVID PCR on 08Jan2021: all Negative. No treatments were received. Outcome of the event headache was recovered. Outcome of the events Fever and body pain was recovered on 08Jan2021 23:30.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; body pain; Headache; This is a spontaneous report from a contactable Nurse (patient). This 40-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 07Jan2021 07:30 A.M. on Arm left at single dose (Lot # EL1283) for covid-19 immunisation. No other vaccine in four weeks. Medical history included Thyroid Cancer. None known allergies. No COVID prior vaccination. Concomitant medications included Levothyroxine and ubrogepant (UBRELVY). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 18Dec2020 04:00 P.M. on Arm left at single dose (Lot # EK5730) for covid-19 immunisation. The patient experienced headache started the day of 07Jan2021 at 21:30. Fever and body pain 08Jan2021 01:30 until 23:30. Lab data included Nasal Swab and COVID PCR on 08Jan2021: all Negative. No treatments were received. Outcome of the event headache was recovered. Outcome of the events Fever and body pain was recovered on 08Jan2021 23:30.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: 36 hours of chills; headache; fever; muscle pain; joint pain; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; This is a spontaneous report from a contactable other health professional (patient). A 50-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL3249), intramuscularly on left arm at 09:00 AM on 08Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroidism. Concomitant medication included levothyroxine. The patient previously received her first dose of BNT162B2 (lot number= EJ1685) intramuscularly on left arm at 08:30 AM on 22Dec2020 for COVID-19 immunization. The patient experienced 36 hours of chills, headache, fever, muscle pain and joint pain at 09:00 AM on 08Jan2021. The patient did not receive any treatment from events. The outcome of events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Off label use
Clinical narrative: 36 hours of chills; headache; fever; muscle pain; joint pain; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; This is a spontaneous report from a contactable other health professional (patient). A 50-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL3249), intramuscularly on left arm at 09:00 AM on 08Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroidism. Concomitant medication included levothyroxine. The patient previously received her first dose of BNT162B2 (lot number= EJ1685) intramuscularly on left arm at 08:30 AM on 22Dec2020 for COVID-19 immunization. The patient experienced 36 hours of chills, headache, fever, muscle pain and joint pain at 09:00 AM on 08Jan2021. The patient did not receive any treatment from events. The outcome of events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product use issue, Pyrexia
Clinical narrative: 36 hours of chills; headache; fever; muscle pain; joint pain; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; dose number= 1: administration date= 22Dec2020/ dose number= 2: administration date= 08Jan2021; This is a spontaneous report from a contactable other health professional (patient). A 50-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL3249), intramuscularly on left arm at 09:00 AM on 08Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroidism. Concomitant medication included levothyroxine. The patient previously received her first dose of BNT162B2 (lot number= EJ1685) intramuscularly on left arm at 08:30 AM on 22Dec2020 for COVID-19 immunization. The patient experienced 36 hours of chills, headache, fever, muscle pain and joint pain at 09:00 AM on 08Jan2021. The patient did not receive any treatment from events. The outcome of events was recovering.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Arthralgia, Chest discomfort, Dyspnoea, Eye pain
Clinical narrative: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Malaise, Nausea, Pain, Sleep disorder
Clinical narrative: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Arthralgia, Body temperature, Chest discomfort, Dyspnoea
Clinical narrative: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Headache, Malaise, Nausea, Oxygen saturation
Clinical narrative: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: itching and covered in hives/ all over her entire body; itching and covered in hives/ all over her entire body; This is a spontaneous report from a contactable other health professional. A 45-year-old female patient (non-pregnant) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI284), via intramuscular on 07Jan2021 17:45 in right arm at single dose for covid-19 immunization. Medical history included hypothyroidism. Known allergies was none. The patient's concomitant medications were not reported. The patient previously took the first does of BNT162B2 via intramuscular from on 17Dec2020 04:30 PM in right arm at single dose for covid-19 immunization. The patient had no COVID prior vaccination and was not tested COVID post vaccination. No problems at all on day 1 or 2 post injection. On day 3 (10Jan2021 12:00 am), patient woke up in the night itching and covered in hives. not just in her right arm, but all over my entire body. Outcome of events was recovering. The patient took diphenhydramine hydrochloride (BENADRYL) for events.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itching and covered in hives/ all over her entire body; itching and covered in hives/ all over her entire body; This is a spontaneous report from a contactable other health professional. A 45-year-old female patient (non-pregnant) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI284), via intramuscular on 07Jan2021 17:45 in right arm at single dose for covid-19 immunization. Medical history included hypothyroidism. Known allergies was none. The patient's concomitant medications were not reported. The patient previously took the first does of BNT162B2 via intramuscular from on 17Dec2020 04:30 PM in right arm at single dose for covid-19 immunization. The patient had no COVID prior vaccination and was not tested COVID post vaccination. No problems at all on day 1 or 2 post injection. On day 3 (10Jan2021 12:00 am), patient woke up in the night itching and covered in hives. not just in her right arm, but all over my entire body. Outcome of events was recovering. The patient took diphenhydramine hydrochloride (BENADRYL) for events.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Malaise, Myalgia, Nausea
Clinical narrative: Nausea; vomiting; headache; fever; malaise; muscle pain; chills; This is a spontaneous report from a contactable Other-health care professional (HCP) (patient). A 35-year-old female patient not pregnant received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Intramuscularly in the Left arm on 08Jan2021 04:00 PM as a single dose for COVID-19 immunization, lot number: unknown. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Patient had not been tested for COVID-19 post vaccination. On 09Jan2021 08:00 AM, patient experienced nausea, vomiting, headache, fever, malaise, muscle pain, chills. No treatment received for the events. Patient recovered from the events on unknown date.  Information on the lot/batch number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Nausea; vomiting; headache; fever; malaise; muscle pain; chills; This is a spontaneous report from a contactable Other-health care professional (HCP) (patient). A 35-year-old female patient not pregnant received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Intramuscularly in the Left arm on 08Jan2021 04:00 PM as a single dose for COVID-19 immunization, lot number: unknown. Medical history was reported as none. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Patient had not been tested for COVID-19 post vaccination. On 09Jan2021 08:00 AM, patient experienced nausea, vomiting, headache, fever, malaise, muscle pain, chills. No treatment received for the events. Patient recovered from the events on unknown date.  Information on the lot/batch number has been requested.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: moderate tiredness; generalized achiness; mild chills/another episode of chills; Bad headache; severe nausea; Left arm pain-mild, less than flu shot pain; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received bnt162b2 (COVID 19, Pfizer, lot number: EL3246), via an unspecified route of administration on the left arm on 08Jan2021 16:45 at a single dose for an COVID-19 immunisation. Medical history included impaired gastroparesis, pancreatitis, hashimoto's thyroiditis, allergies: sulfa and adhesives. The patient's concomitant medications were not reported. The patient has known allergies with pethidine hydrochloride (DEMEROL). The patient is not pregnant. The patient has no COVID prior vaccination and was not COVID tested post vaccination. On 08Jan2021 at 19:45 (3 hours post vaccine), the patient experienced severe nausea that lasted for 29 hours; and left arm pain-mild, less than flu shot pain that lasted 3 days. At 22:45 (6 hours post vaccine), the patient had a bad headache that lasted 29 hours. On 09Jan2021 at 00:45 (8 hours post vaccine), the patient experienced mild chills that lasted 5 minutes, then 02:45 (10 hours post vaccine) another episode of chills that lasted 10 minutes. On 09Jan2021 at 04:45 (12 hours post vaccine), the patient experienced moderate tiredness and generalized achiness that lasted 24 hours. The patient recovered from severe nausea on 10Jan2021 00:45 and bad headache on 10Jan2021 03:45, recovered from left arm pain-mild, less than flu shot pain on 11Jan2021, recovered from chills on 09Jan2021 00:50, and recovered from moderate tiredness and generalized achiness on 10Jan2021 04:45.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: moderate tiredness; generalized achiness; mild chills/another episode of chills; Bad headache; severe nausea; Left arm pain-mild, less than flu shot pain; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received bnt162b2 (COVID 19, Pfizer, lot number: EL3246), via an unspecified route of administration on the left arm on 08Jan2021 16:45 at a single dose for an COVID-19 immunisation. Medical history included impaired gastroparesis, pancreatitis, hashimoto's thyroiditis, allergies: sulfa and adhesives. The patient's concomitant medications were not reported. The patient has known allergies with pethidine hydrochloride (DEMEROL). The patient is not pregnant. The patient has no COVID prior vaccination and was not COVID tested post vaccination. On 08Jan2021 at 19:45 (3 hours post vaccine), the patient experienced severe nausea that lasted for 29 hours; and left arm pain-mild, less than flu shot pain that lasted 3 days. At 22:45 (6 hours post vaccine), the patient had a bad headache that lasted 29 hours. On 09Jan2021 at 00:45 (8 hours post vaccine), the patient experienced mild chills that lasted 5 minutes, then 02:45 (10 hours post vaccine) another episode of chills that lasted 10 minutes. On 09Jan2021 at 04:45 (12 hours post vaccine), the patient experienced moderate tiredness and generalized achiness that lasted 24 hours. The patient recovered from severe nausea on 10Jan2021 00:45 and bad headache on 10Jan2021 03:45, recovered from left arm pain-mild, less than flu shot pain on 11Jan2021, recovered from chills on 09Jan2021 00:50, and recovered from moderate tiredness and generalized achiness on 10Jan2021 04:45.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: Fatigue; Headache; chills; muscle aches; This is a spontaneous report from a contactable healthcare professional (patient). A 43-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as Pfizer COVID-19 vaccine; lot number: EK9231), via an unspecified route of administration left arm on 08Jan2021 08:00 at a single dose for covid-19 immunization. Medical history included asthma, high blood pressure, hypothyroid, insulin resistance and allergies to sulpha. Concomitant medication included liraglutide (VICTOZA), metformin (METFORMIN), levothyroxine sodium (SYNTHROID), losartan potassium (COZAAR). The patient previously took enalapril but had allergies. The patient received her vaccine in a hospital. The patient received his first dose of bnt162b2 (BNT162B2 reported as Pfizer COVID-19 vaccine; lot number: EH9899), via an unspecified route of administration left arm on 08Jan2021 08:00 at a single dose for covid-19 immunization. The patient experienced fatigue, headache, chills and muscle aches on 08Jan2021 02:00 PM (14:00). No treatment was received for the adverse events. The patient was not diagnosed with Covid-19 prior vaccination and has not been tested for Covid-19 post vaccination. The outcome of the events was recovered on Jan2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Oropharyngeal pain
Clinical narrative: Sore area at injection site when touched; very slight sore throat; very slight headache; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EK9231, expiry date unknown), via an unspecified route of administration on the left arm on 10Jan2021 05:00 AM at single dose for COVID-19 immunization. The patient's medical history included asthma, seasonal allergy, and hypothyroid, all from an unknown date. The patient is not pregnant. Concomitant medications included levothyroxine, diphenhydramine hydrochloride (BENADRYL), and basic vitamins; patient also received these medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Jan2021 04:45 AM, the patient experienced sore area at injection site when touched, very slight sore throat and very slight headache. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovering. The events were assessed as non-serious.  Information on the lot/batch number has been obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Sore area at injection site when touched; very slight sore throat; very slight headache; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EK9231, expiry date unknown), via an unspecified route of administration on the left arm on 10Jan2021 05:00 AM at single dose for COVID-19 immunization. The patient's medical history included asthma, seasonal allergy, and hypothyroid, all from an unknown date. The patient is not pregnant. Concomitant medications included levothyroxine, diphenhydramine hydrochloride (BENADRYL), and basic vitamins; patient also received these medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Jan2021 04:45 AM, the patient experienced sore area at injection site when touched, very slight sore throat and very slight headache. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovering. The events were assessed as non-serious.  Information on the lot/batch number has been obtained.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Paraesthesia oral, Throat tightness
Clinical narrative: C/o lightheadedness, throat tightness, brought to ED immediately.  Tx: Benadryl IV, Solu-Medrol IV, Ativan IV.   Improved and discharged in stable condition.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Throat tightness
Clinical narrative: C/o lightheadedness, throat tightness, brought to ED immediately.  Tx: Benadryl IV, Solu-Medrol IV, Ativan IV.   Improved and discharged in stable condition.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Pruritus, Swelling face, Urticaria
Clinical narrative: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Anaphylactic reaction, Fatigue, Flushing, Hyperhidrosis
Clinical narrative: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Fatigue, Flushing, Hyperhidrosis, Inappropriate schedule of product administration
Clinical narrative: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pruritus, SARS-CoV-2 test, Urticaria
Clinical narrative: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Swelling face
Clinical narrative: Swelling in face at temples where I had filler a year ago; right eye area swelled up more until eye was almost closed; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El3246), via an unspecified route of administration on 10Jan2021 12:30 at single dose in left arm for covid-19 immunization. Illness at vaccine included urinary tract infection from Jan2021 and ongoing. Medical history included face at temples where she had filler a year before (in 2019). Concomitant medication included nitrofurantoin for urinary tract infection from 04Jan2021 to 11Jan2021. The patient had historically gotten shingles vaccine, flu vaccine and pneumonia vaccine and never had any problems. The patient experienced swelling in face at temples where she had filler a year before (in 2019) and right eye area swelled up more until eye was almost closed on 10Jan2020 17:00. This consumer had the bnt162b2 on 10Jan2021 at about 12:30pm. On 10Jan2021 around 4:00 pm (reported as "10Jan2020 05:00 pm") she noticed the areas around her temples and under eyes where she had filler placed last year swelled up quite a bit. She read up on this and saw to take antihistamines or oral steroids for this, so she took antihistamines and the event improved, was much better through during the day yesterday (11Jan2021). Last night (11Jan2021) her right eye area swelled up more until eye was almost closed; in response to that event she has been icing the area and the event has improved, swelling come down quite a bit but still ongoing. She called her primary care physician about this event and is waiting for a callback from them about getting a steroid pack. She already reported this information on an unknown Pfizer website online, and also on the VAERS reporting online site today (12Jan2021); but does not have any reference numbers from those reports to provide at this time. She called to ask for information on how to proceed regarding this event; if this has been reported with bnt162b2; if there would be problems with her getting the second dose of bnt162b2 as scheduled on 31Jan2021 because she heard the second dose would be worse. She also noted during this report that she was still taking nitrofurantoin for urinary tract infection when she received that first dose of bnt162b2; she asked if that could have any correlation with event or be a problem taken together. She reported by the time she got that first dose the urinary tract infection itself was gone. Caller verified that she received no other vaccines on the date of first dose of bnt162b2 and onset of adverse event. She verified that she had not received any other vaccines in the 4 weeks prior to the first dose of bnt162b2 and onset of adverse event. She verified that she has no history of any adverse events with any other vaccines. The outcome of the events was recovering.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Injection site pain, Myalgia, Nausea
Clinical narrative: Injection site pain; chills; fever; headache; muscle pain; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old female patient received the second dose of BNT162B2 (Pfizer, lot number: EL3246), intramuscularly in left arm on 08Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included known allergies: sulfa drugs. Concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: EK5730), intramuscularly in left arm on 21Dec2020 17:00 for COVID-19 immunization. Patient experienced injection site pain, chills, fever, headache, muscle pain, and nausea 12 hours after second vaccine on 08Jan2021 22:00. No treatment was received. Patient was recovered from these events.  No follow-up attempts are possible; no information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Injection site pain; chills; fever; headache; muscle pain; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old female patient received the second dose of BNT162B2 (Pfizer, lot number: EL3246), intramuscularly in left arm on 08Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included known allergies: sulfa drugs. Concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: EK5730), intramuscularly in left arm on 21Dec2020 17:00 for COVID-19 immunization. Patient experienced injection site pain, chills, fever, headache, muscle pain, and nausea 12 hours after second vaccine on 08Jan2021 22:00. No treatment was received. Patient was recovered from these events.  No follow-up attempts are possible; no information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Injection site pain; chills; fever; headache; muscle pain; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old female patient received the second dose of BNT162B2 (Pfizer, lot number: EL3246), intramuscularly in left arm on 08Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included known allergies: sulfa drugs. Concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: EK5730), intramuscularly in left arm on 21Dec2020 17:00 for COVID-19 immunization. Patient experienced injection site pain, chills, fever, headache, muscle pain, and nausea 12 hours after second vaccine on 08Jan2021 22:00. No treatment was received. Patient was recovered from these events.  No follow-up attempts are possible; no information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; chills; fever; headache; muscle pain; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old female patient received the second dose of BNT162B2 (Pfizer, lot number: EL3246), intramuscularly in left arm on 08Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included known allergies: sulfa drugs. Concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: EK5730), intramuscularly in left arm on 21Dec2020 17:00 for COVID-19 immunization. Patient experienced injection site pain, chills, fever, headache, muscle pain, and nausea 12 hours after second vaccine on 08Jan2021 22:00. No treatment was received. Patient was recovered from these events.  No follow-up attempts are possible; no information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Eye pruritus, Eye swelling, Lacrimation increased, Paraesthesia
Clinical narrative: eyes are swollen and itchy; eyes are swollen and itchy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose as a COVID-19 vaccine. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine) on an unspecified date. The patient just got the second vaccine and experienced side effects as eyes were swollen and itchy on an unspecified date and had to take Claritin and Benadryl. There was no swelling of the face/tongue. The patient was asking if this was normal and what should they do. Outcome of the events was unknown.  Information about the lot/batch has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral coldness, Scleral oedema, Wheezing
Clinical narrative: eyes are swollen and itchy; eyes are swollen and itchy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose as a COVID-19 vaccine. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine) on an unspecified date. The patient just got the second vaccine and experienced side effects as eyes were swollen and itchy on an unspecified date and had to take Claritin and Benadryl. There was no swelling of the face/tongue. The patient was asking if this was normal and what should they do. Outcome of the events was unknown.  Information about the lot/batch has been requested.